Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Debt to Equity (2018 - 2020)

Historic Debt to Equity for Neurocrine Biosciences (NBIX) over the last 3 years, with Q3 2020 value amounting to $0.53.

  • Neurocrine Biosciences' Debt to Equity changed N/A to $0.53 in Q3 2020 from the same period last year, while for Sep 2020 it was $0.53, marking a year-over-year change of. This contributed to the annual value of $0.64 for FY2019, which is N/A changed from last year.
  • Latest data reveals that Neurocrine Biosciences reported Debt to Equity of $0.53 as of Q3 2020.
  • Neurocrine Biosciences' Debt to Equity's 5-year high stood at $0.86 during Q3 2018, with a 5-year trough of $0.5 in Q2 2020.
  • For the 3-year period, Neurocrine Biosciences' Debt to Equity averaged around $0.63, with its median value being $0.59 (2020).